Skip to content
SEARCH icon
  • Investing
  • Market News
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Technology
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Market News
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Technology
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
icon

      HomeBiotech

      Biotech

      FDA Grants Breakthrough Device Designation to Amadix´s preventive screening blood test for Colorectal Cancer
      Biotech

      FDA Grants Breakthrough Device Designation to Amadix´s preventive screening blood test for Colorectal Cancer

      January 23, 2024
      Vesper Bio awarded grant by The Michael J. Fox Foundation to assess sortilin inhibitors in the treatment of Parkinson’s disease
      Biotech

      Vesper Bio awarded grant by The Michael J. Fox Foundation to assess sortilin inhibitors in the treatment of Parkinson’s disease

      January 23, 2024
      Solvias to Perform Release Testing on World’s First CRISPR-based Gene-Editing Therapy
      Biotech

      Solvias to Perform Release Testing on World’s First CRISPR-based Gene-Editing Therapy

      January 23, 2024
      Kimera® Labs Responds to FDA Warning Letter
      Biotech

      Kimera® Labs Responds to FDA Warning Letter

      January 23, 2024
      Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B
      Biotech

      Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B

      January 23, 2024
      Gannex’s Strategic Partner Sagimet Biosciences Announces Positive Topline Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 NASH
      Biotech

      Gannex’s Strategic Partner Sagimet Biosciences Announces Positive Topline Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 NASH

      January 23, 2024
      PeproMene Bio, Inc. Announces Complete Remission of the Cohort 1 First Patient Treated for Relapsed and Refractory B-cell Acute Lymphoblastic Leukemia (B-ALL) in the Phase 1 Clinical Trial of PMB-CT01 (BAFFR-CAR T Cells) at City of Hope
      Biotech

      PeproMene Bio, Inc. Announces Complete Remission of the Cohort 1 First Patient Treated for Relapsed and Refractory B-cell Acute Lymphoblastic Leukemia (B-ALL) in the Phase 1 Clinical Trial of PMB-CT01 (BAFFR-CAR T Cells) at City of Hope

      January 18, 2024
      « 1 … 28 29 30

       

      LATEST NEWS

      • Investing News Pfizer Stock Analysis: Post-Deal Rally
      • Investing News Tesla Q3 Deliveries: A Record Quarter
      • Investing News PepsiCo Natural Dyes: Transforming Iconic Snacks
      • Investing News Intel Stock 2025: Buy, Sell, or Hold After Nvidia’s $5B Bet?

      UpAlpha

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from UpAlpha.

      I want e-mail alerts, updates, and offers and agree to the UpAlpha privacy policy.

      Market Jar Media Inc. © 2025